Home/Filings/4/0001980648-26-000002
4//SEC Filing

Lee Chan Henry 4

Accession 0001980648-26-000002

CIK 0001651308other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 5:15 PM ET

Size

17.2 KB

Accession

0001980648-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-07
Lee Chan Henry
SVP, General Counsel
Transactions
  • Exercise/Conversion

    American Depositary Shares

    2026-01-07$194.47/sh+202$39,283202 total
  • Exercise/Conversion

    American Depositary Shares

    2026-01-07$213.32/sh+266$56,743468 total
  • Exercise/Conversion

    American Depositary Shares

    2026-01-07$159.03/sh+196$31,170664 total
  • Sale

    American Depositary Shares

    2026-01-07$331.76/sh664$220,2890 total
  • Exercise/Conversion

    Share Option (Right to Buy)

    2026-01-072,62630,446 total
    Exercise: $14.96Exp: 2032-08-04Ordinary Shares (2,626 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    2026-01-073,45897,019 total
    Exercise: $16.41Exp: 2033-06-14Ordinary Shares (3,458 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    2026-01-072,548118,118 total
    Exercise: $12.23Exp: 2034-06-04Ordinary Shares (2,548 underlying)
Holdings
  • Ordinary Shares

    223,106
Footnotes (6)
  • [F1]Each American Depositary Share represents 13 Ordinary Shares.
  • [F2]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.
  • [F3]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
  • [F4]These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F5]These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
  • [F6]These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Issuer

BeOne Medicines Ltd.

CIK 0001651308

Entity typeother

Related Parties

1
  • filerCIK 0001980648

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:15 PM ET
Size
17.2 KB